RANDI RABIN: Open Payments
NPI 1538268644 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,985 in 35 payments from 16 companies in 2025. Trend: 2023 $461 · 2024 $693 · 2025 $9,985
Consulting: $5,183Travel & lodging: $4,120Food & beverage: $682
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $6,139 |
| Janssen Scientific Affairs, LLC | 12 | $2,608 |
| Janssen Global Services, LLC | 1 | $900 |
| Incyte Corporation | 2 | $49 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Iovance Biotherapeutics, Inc. | 1 | $36 |
| Celgene Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| ARRAY BIOPHARMA INC | 1 | $23 |
| SERVIER PHARMACEUTICALS LLC | 1 | $22 |
Products named: RYBREVANT, Jakafi, Amtagvi, Enhertu, REBLOZYL, KISQALI, LORBRENA, Tibsovo.
Industry payments across VA — which companies pay providers there.
